title: Axitinib induces paradoxical erythropoietin synthesis in metastatic renal cell carcinoma.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Alexandre
authors.forename: Bertrand
authors.initials: B
authors.lastname: Billemont
authors.forename: Jean Baptiste
authors.initials: JB
authors.lastname: Meric
authors.forename: Stephane
authors.initials: S
authors.lastname: Richard
authors.forename: Olivier
authors.initials: O
authors.lastname: Rixe
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004921:Erythropoietin / Q000096:biosynthesis*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D007191:Indazoles / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D007191:Indazoles; D004921:Erythropoietin; D000077784:Axitinib; D011505:Protein-Tyrosine Kinases